Sular and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sular (nisoldipine) and Zofran (ondansetron hydrochloride). Common drug interactions include nasopharyngitis among females and multiple sclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Sular and Zofran. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Sular?

Sular has active ingredients of nisoldipine. It is often used in high blood pressure. eHealthMe is studying from 1,757 Sular users. Check the latest studies of Sular.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.



On Jul, 28, 2026

20 people who take Sular and Zofran together, and have interactions are studied.

Sular and Zofran drug interactions.

What are the common drug interactions of Sular and Zofran, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Nervousness
  3. Oedema peripheral (superficial swelling)
  4. Pain
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Post procedural complication
  7. Pyelonephritis (inflammation of kidney caused by bacteria)
  8. Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
  9. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  10. Sinusitis (inflammation of sinus)

male:

  1. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Fatigue (feeling of tiredness)
  3. International normalised ratio increased
  4. Pleural effusion (water on the lungs)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Respiratory distress (difficulty in breathing)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Asthenia (weakness)
  9. Chills (felling of cold)
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Sular and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Nervousness
  2. Pain
  3. Pneumonia
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Pyelonephritis (inflammation of kidney caused by bacteria)
  6. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  7. Sinusitis (inflammation of sinus)
  8. Tardive dyskinesia (a disorder that involves involuntary movements)
  9. Urinary tract infection
  10. Vaginal haemorrhage (vaginal bleeding)

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiac arrest
  2. Collapse (sudden functional breakdown)
  3. Dehydration (dryness resulting from the removal of water)
  4. Loss of consciousness
  5. Vasovagal attack (malaise mediated by the vagus nerve)
  6. Hypotension (abnormally low blood pressure)
  7. Pulse absent
  8. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Anger

60+:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Headache (pain in head)
  5. Hypokalaemia (low potassium)
  6. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Pleural effusion (water on the lungs)
  8. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  9. Respiratory distress (difficulty in breathing)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 25.00%
  2. Pancreatic Insufficiency: 2 people, 10.00%
  3. Nausea And Vomiting: 2 people, 10.00%
  4. Multiple Myeloma (cancer of the plasma cells): 2 people, 10.00%
  5. Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 5.00%
  6. Pancreatic Carcinoma (pancreatic cancer): 1 person, 5.00%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%
  8. Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.00%
  9. Infection: 1 person, 5.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sular and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sular and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sular and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nisoldipine and ondansetron hydrochloride (the active ingredients of Sular and Zofran, respectively), and Sular and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: